Company news
CareDx, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App
August 3, 2022
CareDx Reports Second Quarter 2022 Results
August 3, 2022
CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care
August 1, 2022
CareDx to Report Second Quarter 2022 Financial Results
July 27, 2022
CareDx Demonstrates Industry-Leading Commitment to Advancing Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 2022 American Society of Transplant Surgeons Symposium
July 27, 2022
CareDx Lead Sponsor for 2022 Donate Life Transplant Games
June 27, 2022
CareDx The Transplant Company Releases Inaugural Environmental, Social and Governance Report
June 20, 2022
CareDx To Participate in Upcoming Jefferies Healthcare Conference
June 1, 2022
CareDx Leads Transplant Innovation with AiKidney, an AI Clinical Decision Support Tool for Predicting Allograft Rejection Risk
June 1, 2022
CareDx Innovation Showcased in Record-Breaking Number of Scientific Abstracts with Over 50 Presented at 2022 Transplant Congress
May 31, 2022
CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation
May 23, 2022
CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction
May 17, 2022
In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx
May 16, 2022
CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference
May 10, 2022
CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection
May 4, 2022
CareDx Reports First Quarter 2022 Results
May 4, 2022
CareDx Extends Artificial Intelligence Leadership to Heart Transplantation
April 27, 2022
CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award
April 27, 2022
CareDx to Report First Quarter 2022 Financial Results
April 26, 2022
CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings
April 21, 2022
CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation
April 20, 2022
CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting
April 19, 2022
CareDx Reports Over 200,000 Heart Transplant Patient Results Served
April 13, 2022
CareDx, the Leading Sponsor of UNOS Transplant Management Forum, Demonstrates the Value of Digital Solutions to Improve Pre-Transplant Patient Referral and Waitlisting Workflow
April 10, 2022
CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance
April 5, 2022
CareDx Partners with the European Society for Organ Transplantation to Provide Clinical Evidence Supporting the Use of AlloSeq cfDNA with European Transplant Healthcare Professionals
March 29, 2022
CareDx Partners with HeartBrothers Foundation to Help Patients Living with Heart Failure and Heart Transplant
March 28, 2022
CareDx’s AlloCare App Now Integrated with TxAccess to Help Pre-Transplant Patients Navigate the Waitlist Process
March 23, 2022
UPDATE -- CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community
March 22, 2022
CareDx Announces XenoSure and XenoMap
March 22, 2022
CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation
March 15, 2022
CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community
March 13, 2022
CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients
March 2, 2022
CareDx Partners with the National Kidney Foundation to Advocate for Kidney Transplant Patients
March 1, 2022
CareDx Reports Fourth Quarter and Full Year 2021 Results
February 23, 2022
CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring World’s First Successful Living Xenotransplantation
February 21, 2022
CareDx to Report Fourth Quarter and Full Year 2021 Financial Results
February 16, 2022
On National Donor Day, CareDx Applauds Patient Advocacy Efforts Aimed at Increasing Donations for the Thousands of Patients Waiting for a Transplant
February 13, 2022
CareDx Taps into Its Patient Network to Deliver Insights on Transplant Needs
February 7, 2022
CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education Program, to Host “Heart Health” Webinar for Transplant Patients
February 6, 2022
CareDx To Participate In Upcoming Conferences
February 2, 2022
CareDx Joins Forces with MOTTEP to Increase Organ Donations for Minority Transplant Patients and Support High-Risk, Underserved Communities
January 19, 2022
Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance
January 11, 2022
CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies
January 10, 2022
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021
January 9, 2022
NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection
January 6, 2022
CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial Launch
January 5, 2022
CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy
January 4, 2022
CareDx Partners with ISHLT in a Transplant Innovation Research Grant to Improve Outcomes for Heart and Lung Transplant Patients
January 3, 2022
CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes
December 15, 2021
Calls
The 5 newest of 25 calls. Every call is listed under its year.
- Caredx (NASDAQ:CDNA) Q3 2026 Earnings Call
Oct 29, 2026
Transcript - Caredx (NASDAQ:CDNA) Q2 2026 Earnings Call
Jul 30, 2026
Transcript - Caredx (NASDAQ:CDNA) Q1 2026 Earnings Call
Apr 28, 2026
Transcript - Caredx (NASDAQ:CDNA) Q4 2025 Earnings Call
Feb 24, 2026
Transcript - Caredx (NASDAQ:CDNA) Q3 2025 Earnings Call
Nov 4, 2025
Transcript
Decks
The 5 newest of 23 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 28 slides · Oct 29, 2026
- Q2 2026 Earnings Presentation
Earnings · 26 slides · Jul 30, 2026
- Q1 2026 Earnings Presentation
Earnings · 37 slides · Apr 28, 2026
- Q4 2025 Earnings Presentation
Earnings · 29 slides · Feb 24, 2026
- Investor Presentation (February 2026)
Investor deck · 35 slides · Feb 12, 2026